Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Cantor Fitzgerald
Cipla
Citi
Moodys
US Department of Justice

Generated: September 16, 2019

DrugPatentWatch Database Preview

Patent: 6,719,540

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 6,719,540
Title: C3-cyano epothilone derivatives
Abstract:The present invention relates to compounds useful in the treatment of cancer or other proliferative diseases represented by formula I: ##STR1## wherein: Q is selected from the group consisting of ##STR2## M is O, NR.sub.9, or CR.sub.10 R.sub.11 ; X is O or NH; and the R groups are as defined, and therapeutic compositions containing them alone or in combination with other therapeutic agents useful in the treatment of cancer or other proliferative diseases.
Inventor(s): Regueiro-Ren; Alicia (Middletown, CT), Kim; Soong-Hoon (Titusville, NJ)
Assignee: Bristol-Myers Squibb Company (Princeton, NJ)
Application Number:10/386,072
Patent Claims:see list of patent claims

Details for Patent 6,719,540

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Chiron PROLEUKIN aldesleukin VIAL 103293 001 1992-05-05   Try a Free Trial Bristol-Myers Squibb Company (Princeton, NJ) 2022-03-12 RX search
Amgen NEUPOGEN filgrastim VIAL 103353 001 1991-02-20   Try a Free Trial Bristol-Myers Squibb Company (Princeton, NJ) 2022-03-12 RX search
Amgen NEUPOGEN filgrastim VIAL 103353 002 1991-02-20   Try a Free Trial Bristol-Myers Squibb Company (Princeton, NJ) 2022-03-12 RX search
Amgen NEUPOGEN filgrastim SYRINGE 103353 003 1991-02-20   Try a Free Trial Bristol-Myers Squibb Company (Princeton, NJ) 2022-03-12 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Citi
Daiichi Sankyo
Teva
Moodys
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.